Chaparral Labs
back to search

protein

Medium-chain acyl-CoA ligase ACSF2, mitochondrial

ACSF2
protein:Q96CM8disease:adad:direction:up

Gene

ACSF2

Organism

Homo sapiens(9606)

Length

615 aa

Mass

68,125 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

ACSF2 is a mitochondrial medium-chain acyl-CoA ligase that catalyzes the initial step of fatty acid metabolism by forming a thioester with CoA (UniProt: Q96CM8). The enzyme shows preference for medium-chain substrates and is known to participate in adipocyte differentiation.

ACSF2 is localized to mitochondria and functions in the fatty acid β-oxidation pathway, which is central to cellular energy metabolism (UniProt: Q96CM8). No disease associations are documented in UniProt's curated disease field.

ACSF2 is elevated in Alzheimer's Disease brain tissue. Analysis of post-mortem AD brain compared to age-matched controls by quantitative proteomics (TMT-labeled, DDA mass spectrometry across four subcellular fractions) showed ACSF2 upregulation with a mean log2 fold-change of 0.44 (Chaparral AD proteomics). This increase may reflect altered lipid metabolism in AD pathology, though the biological significance requires further investigation.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↑ Up in AD

P3

not detected

P2

+0.443

S2

not detected

S3

not detected

Mean log₂FC across detected fractions: +0.4425 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA (PubMed:17762044). Has some preference toward medium-chain substrates (PubMed:17762044). Plays a role in adipocyte differentiation (PubMed:16380219)

Sources

Last updated 5/8/2026, 6:38:01 AM